177 related articles for article (PubMed ID: 2160958)
1. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex.
Marcheselli VL; Rossowska MJ; Domingo MT; Braquet P; Bazan NG
J Biol Chem; 1990 Jun; 265(16):9140-5. PubMed ID: 2160958
[TBL] [Abstract][Full Text] [Related]
2. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
3. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
Kudolo GB; Harper MJ
Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
[TBL] [Abstract][Full Text] [Related]
4. Presence of specific platelet-activating factor binding sites in the rat retina.
Thierry A; Doly M; Braquet P; Cluzel J; Meyniel G
Eur J Pharmacol; 1989 Apr; 163(1):97-101. PubMed ID: 2545464
[TBL] [Abstract][Full Text] [Related]
5. Specific receptor sites for platelet activating factor on rat liver plasma membranes.
Hwang SB
Arch Biochem Biophys; 1987 Sep; 257(2):339-44. PubMed ID: 2821908
[TBL] [Abstract][Full Text] [Related]
6. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
7. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
8. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
Lalouette F; Diserbo M; Martin C; Verdetti J; Fatome M
Neurosci Lett; 1995 Feb; 186(2-3):173-6. PubMed ID: 7777190
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Grassi S; Francescangeli E; Goracci G; Pettorossi VE
J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
[TBL] [Abstract][Full Text] [Related]
10. Binding of platelet activating factor by isolated membranes from U937 cells.
Lee JS; Ong R; Yoo TJ; Chiang T
Cell Immunol; 1990 Feb; 125(2):415-25. PubMed ID: 2153465
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
[TBL] [Abstract][Full Text] [Related]
12. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
13. PAF binding to a single receptor in corneal epithelium plasma membrane.
Hurst J; Ma X; Bazan HE
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
[TBL] [Abstract][Full Text] [Related]
14. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists.
Ostermann G; Lorenz A; Hofmann B; Kertscher HP
J Lipid Mediat; 1991 Nov; 4(3):289-98. PubMed ID: 1662546
[TBL] [Abstract][Full Text] [Related]
15. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
19. Specific receptor sites for PAF in iris and ciliary body of the rabbit eye.
van Delft JL; van Haeringen NJ; Verbeij NL; Domingo MT; Chabrier PE; Braquet P
Curr Eye Res; 1988 Nov; 7(11):1063-8. PubMed ID: 2854038
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures.
Rougier F; Dupuis F; Cornu E; Dulery C; Praloran V; Denizot Y
J Lipid Mediat Cell Signal; 1997 Jul; 16(3):147-53. PubMed ID: 9246604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]